Location permission needed for a better experience.
How can we help you?
CV
MEMBERSHIPS
PUBLICATIONS
EDUCATION
  • 2018 Okmeydanı Eğitim ve Araştırma Hastanesi Tıbbi Onkoloji
  • 2014 Medeniyet Üniversitesi Göztepe Eğitim ve Araştırma Hastanesi İç Hastalıkları
  • 2009 Çukurova Üniversitesi Tıp Fakültesi
EXPERIENCE
  • 2023 Acıbadem Sağlık Grubu
  • 2018 - 2021 İstanbul Prof. Dr. Cemil Tasçıoğlu Şehir Hastanesi / Tıbbi Onkoloji / Uzman Doktor
  • 2018 Nevşehir Devlet Hastanesi / Tıbbi Onkoloji / Uzman Doktor
  • 2015 - 2018 İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi / Yandal Asistanı
  • 2014 - 2015 Kırklareli Pınarhisar Devlet Hastanesi / İç Hastalıkları / Uzman Doktor
  • 2009 Mersin Tarsus Çiçekli Sağlık Ocağı/ Pratisyen Hekim
MEMBERSHIPS
  • TTOD (Türk Tıbbi Onkoloji Derneği)
  • ESMO ( European Society for Medical Oncology )
  • ASCO (American Society of Clinical Oncology)
PUBLICATIONS
  • Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium Urologia Internationalis, 107(6), 595-601., Doi: 10.1159/000528994 (Yayın No: 8436265) (2023) EROL CİHAN, YEKEDUZ EMRE, TURAL DENİZ, KARAKAYA SERDAR, ŞENTÜRK ÖZTAŞ NİHAN, UÇAR GÖKHAN, KILIÇKAP SADETTİN, ERTÜRK İSMAİL, SEVER ÖZLEM NURAY, ARSL
  • External Validation of a Novel Risk Model in Patients With Favorable Risk Renal Cell Carcinoma Defined by International Metastatic Renal Cell Carcinoma Database Consortium (IMDC): Results From the Turkish Oncology Group Kidney Cancer Consortium (TKCC) Database Clinical Genitourinary Cancer, 21(1), 175-182., Doi: 10.1016/j.clgc.2022.07.006 (Yayın No: 8124532) (2023) YEKEDÜZ EMRE, KARAKAYA SERDAR, ERTÜRK İSMAİL, TURAL DENİZ, UÇAR GÖKHAN, ŞENTÜRK ÖZTAŞ NİHAN, ARIKAN RUKİYE, HIZAL MUTLU, KÜÇÜKARDA AHMET, SEVER ÖZL
  • How reliable is the high-volume definition in prostate cancer patients: the potential game-changing role of PSMA Nuclear Medicine Communications, 44(9), 816-824., Doi: 10.1097/MNM.0000000000001722 (Yayın No: 8436253 (2023)) GÜVEN OSMAN, KARYAĞAR SAVAŞ, ARICI SERDAR, ÖZÜLKER TAMER, CAN ORÇUN
  • Serum fetuin-A and RANKL levels in patients with early stage breast cancer Journal of Medical Biochemistry, 42(2), 249-257., Doi: 10.5937/jomb0-37386 (Yayın No: 8436129) (2023) AVŞAR USUL ÇİĞDEM, ARAL HALE, CAN ORÇUN, CAN TRABLUS DİDEM, KARAÇETİN DİDEM, NAZLI MEHMET ALİ, GÜRSU RIZA UMAR, KARABULUT SENEM
  • Efficacy of Imatinib on Advanced and Refractory Desmoid Tumors: A Retrospective Study. Journal of Oncological Sciences (JOS), 8(2), 63-68., Doi: 10.37047/jos.2021-87391 (Kontrol No: 8214846) (2022) ATCI MUHAMMED MUSTAFA, CAN ORÇUN, SEÇMELER ŞABAN, SAKİN ABDULLAH, AY ERSOY SEVAL, CİHAN ŞENER, SELVİ OĞUZHAN, GEREDELİ ÇAĞLAYAN
  • The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab i in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study Journal of Cancer Research and Clinical Oncology, 148(12), 3537-3546., Doi: 10.1007/s00432-022-04055-5 (Yayın No: 7696517) (2022) YEKEDÜZ EMRE, TURAL DENİZ, ERTÜRK İSMAİL, KARAKAYA SERDAR, EROL CİHAN, ERCELEP ÖZLEM, ARSLAN ÇAĞATAY, SEVER ÖZLEM NURAY, KILIÇKAP SAADETTİN, ŞENTÜR
  • The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors. Scientific Reports, 12(1), 1-9., Doi: 10.1038/s41598-022-20056-3 (Yayın No: 7307182) (2022) BİR YÜCEL KADRİYE, YEKEDÜZ EMRE, KARAKAYA SERDAR, TURAL DENİZ, ERTÜRK İSMAİL, EROL CİHAN, ERCELEP ÖZLEM, ŞENTÜRK ÖZTAŞ NİHAN, ARSLAN ÇAĞATAY, UÇAR
  • Efect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter Study Oncology Research and Treatment, 45(5), 254-261., Doi: 10.1159/000521980 (Yayın No: 7571177) (2022) ATÇI MUHAMMED MUSTAFA, AKAGÜNDÜZ BARAN, DEMİR METİN, DÖNMEZ YILMAZ BİNNUR, AKIN TELLİ TUĞBA, CAN ORÇUN, ÇİL İBRAHİM, GÖKTAŞ AYDIN SABİN, ÖZYURT NES
  • Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database. Future Oncology, 17(35), 4861-4869., Doi: 10.2217/fon-2021-0717 (Yayın No: 7506054) (2021) YEKEDÜZ EMRE, ERTÜRK İSMAİL, TURAL DENİZ, KARADURMUŞ NURİ, KARAKAYA SERDAR, HIZAL MUTLU, ARIKAN RUKİYE, ARSLAN ÇAĞATAY, TABAN HAKAN, KÜÇÜKARDA AHME
  • Survival and Prognostic Factors in Limited-stage Small-cell Lung Cancer. JCPSP-Journal of The College of Physicians and Surgeons Pakistan, 31(12), 1433-1437., Doi: 10.29271/jcpsp.2021.12.1433 (Yayın No: 8215561) (2021) ATCI MUHAMMED MUSTAFA, SAKİN ABDULLAH, UYSAL EMRE, AKSARAY FERDİ, SELVİ OĞUZHAN, CAN ORÇUN

INFORMATION FORM WITH REGARD TO OBTAINING AND PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. (“Acıbadem”) and Acıbadem’s controlling shareholders, parent companies and affiliates (hereinafter to be collectively referred to as “Acıbadem Group”) may, acting as “Data Supervisor” under the Law on Protection of Personal Data no. 6698 (the “Law”) and other pertinent laws and regulations, process your personal data within the following frame and in strict compliance with the Basic Healthcare Services Law no. 3359, the Governmental Decree-Law on Organization and Duties of the Ministry of Health and its Affiliated Companies no. 663, the Private Hospitals Regulation, and other regulations of the Ministry of Health, and other applicable laws and provisions.

1. Obtaining and Processing of Personal Data, and Purposes of Processing:

Your personal data is collected and obtained verbally, in writing, or in visual or electronic media, through call center, internet site, verbally, in writing or similar other channels for conduct of such services as protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services offered by Acıbadem Group, or for planning and management of healthcare services and financing, and in accordance with the fields of business of Acıbadem Group Companies. Your general personal data and special personal data, especially your healthcare data, may be processed by the Group to a limited extent for all and any purposes, including, but not limited to, the following purposes:

All kinds of your personal data obtained by Acıbadem Group (including, but not limited to, your special personal data) may be processed for the following purposes:

Your personal data obtained and processed pursuant to the applicable laws and regulations may be transferred to physical archives and/or information systems of Acıbadem or Acıbadem Group and may be kept and stored both in digital and in physical platforms.

2. Transfer of Personal Data

Your personal data may be shared by Acıbadem and Acıbadem Group with companies included in Acıbadem Group or with private insurance companies, Ministry of Health and its sub-units, Social Security Agency, Security General Directorate and other security forces, General Directorate of Population and Census, Turkish Pharmacists’ Association, courts and all kinds of other juridical authorities, central etc. third parties, your authorized representatives and agents, and third parties offering consulting and advice services to us, including, but not limited to, lawyers, tax and financial consultants and auditors, and our business partners and other third parties acting in cooperation with us for further development or performance of healthcare services for the purposes cited above, also including regulatory and supervisory bodies and authorities, and official authorities, for the purposes of processing listed above, in accordance with the Law and other applicable laws and regulations.

3. Methods and Legal Causes of Obtaining of Personal Data

Your personal data are collected and processed in all kinds of verbal, written, visual or electronic media, for the purposes listed hereinabove, and for performance of all kinds of works included in the fields of business of Acıbadem within the legal framework, and accordingly, for full and proper performance of all kinds of contractual and legal duties and obligations of Acıbadem. Legal causes of collection and acquisition of your personal data are the pertinent provisions of:

Furthermore, as stipulated in 3rd paragraph of article 6 of the Law, personal data relating to health may also be processed by persons under secrecy obligations or by authorized official entities and organizations, without being liable to receive prior explicit consent of the relevant purpose, only for protection of public health, preventive medicine, medical diagnosis, treatment and maintenance services, and for planning and management of healthcare services and financing.

4. Your Rights Regarding Protection of Personal Data

Pursuant to the Law and other relevant applicable laws and regulations, you are entitled:

If at any time you use any one or more of your aforesaid rights, the relevant information will be transmitted to you clearly and in an understandable manner, in writing or in electronic media, by using the communication data and information provided by you.

5. Data Security

Acıbadem protects your personal data in full and strict compliance with all technical and administrative security controls required to be taken in accordance with information security standards and procedures. Said security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

6. Complaints and Communications

Your personal data are protected within the frame of the available technical and administrative possibilities, and the required security actions and measures are taken and provided at a level appropriate for the probable risks by also taking into consideration the technological possibilities.

By filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the , “https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html” web address, you may transmit and submit your legal requests:

You are hereby kindly requested to transmit your legal requests under the Law by filling in the “Application Form Pursuant to the Law on Protection of Personal Data” given at the https://www.acibadem.com.tr/acibademonline/hastaverilerinkorunmasi.html web address and sending it to us by the communication means set forth in the form.

TOP